A detailed history of Tucker Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tucker Asset Management LLC holds 1,945 shares of ABBV stock, worth $334,014. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,945
Previous 2,145 9.32%
Holding current value
$334,014
Previous $391 Million 14.59%
% of portfolio
0.07%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $30,958 - $36,152
-200 Reduced 9.32%
1,945 $334 Million
Q4 2023

Mar 04, 2024

SELL
$137.6 - $154.97 $412 - $464
-3 Reduced 0.14%
2,145 $332 Million
Q3 2023

Dec 04, 2023

SELL
$133.59 - $154.65 $9,885 - $11,444
-74 Reduced 3.33%
2,148 $320 Million
Q2 2023

Sep 08, 2023

BUY
$132.51 - $164.9 $11,660 - $14,511
88 Added 4.12%
2,222 $299 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $282,423 - $325,252
1,953 Added 1079.01%
2,134 $340 Million
Q4 2022

May 11, 2023

SELL
$138.31 - $165.87 $4,287 - $5,141
-31 Reduced 1.36%
2,253 $366 Million
Q3 2022

May 11, 2023

BUY
$134.21 - $153.93 $402 - $461
3 Added 0.13%
2,284 $334 Million
Q2 2022

May 11, 2023

BUY
$137.62 - $174.96 $301,250 - $382,987
2,189 Added 2379.35%
2,281 $349 Million
Q1 2022

May 11, 2023

BUY
$131.98 - $163.75 $23,888 - $29,638
181 New
181 $29.4 Million
Q4 2021

May 11, 2023

SELL
$107.43 - $135.93 $219,372 - $277,569
-2,042 Reduced 95.69%
92 $12.5 Million
Q3 2021

Aug 10, 2023

BUY
$106.4 - $120.78 $5,320 - $6,039
50 Added 119.05%
92 $10.6 Million
Q1 2021

Aug 10, 2023

SELL
$102.3 - $112.62 $214,011 - $235,601
-2,092 Reduced 98.03%
42 $4.55 Million
Q4 2020

Jun 07, 2023

SELL
$80.49 - $108.67 $170,397 - $230,054
-2,117 Reduced 99.2%
17 $1.82 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tucker Asset Management LLC Portfolio

Follow Tucker Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tucker Asset Management LLC with notifications on news.